Senores Pharmaceuticals Limited — Updates, 04-02-2026: General Updates

Senores Pharma clarified details for its 11,70,000 preferential equity warrants. An independent valuer set the fair value at ₹812.00 per share, assigning 100% weight to the market approach. This aligns with the company's Articles for floor price determination.